Overview

Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers.

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Study to evaluate the safety and tolerability of PRO-155 Ophthalmic Solution 0.09 % in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Laboratorios Sophia S.A de C.V.
Treatments:
Bromfenac
Ophthalmic Solutions
Pharmaceutical Solutions